ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease

https://repo.qst.go.jp/records/84787
https://repo.qst.go.jp/records/84787
1c4fa6a3-649f-4437-a657-388c216feef0
Item type 学術雑誌論文 / Journal Article(1)
公開日 2021-12-15
タイトル
タイトル Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Saito, Takashi

× Saito, Takashi

WEKO 1043273

Saito, Takashi

Search repository
Ohnishi, Kayoko

× Ohnishi, Kayoko

WEKO 1043274

Ohnishi, Kayoko

Search repository
Ishikawa, Hitoshi

× Ishikawa, Hitoshi

WEKO 1043275

Ishikawa, Hitoshi

Search repository
Nakamura, Masatoshi

× Nakamura, Masatoshi

WEKO 1043276

Nakamura, Masatoshi

Search repository
Hoshiai, Sodai

× Hoshiai, Sodai

WEKO 1043277

Hoshiai, Sodai

Search repository
Numajiri, Haruko

× Numajiri, Haruko

WEKO 1043278

Numajiri, Haruko

Search repository
Nemoto Murofushi, Keiko

× Nemoto Murofushi, Keiko

WEKO 1043279

Nemoto Murofushi, Keiko

Search repository
Mizumoto, Masashi

× Mizumoto, Masashi

WEKO 1043280

Mizumoto, Masashi

Search repository
Okumura, Toshiyuki

× Okumura, Toshiyuki

WEKO 1043281

Okumura, Toshiyuki

Search repository
Sakurai, Hideyuki

× Sakurai, Hideyuki

WEKO 1043282

Sakurai, Hideyuki

Search repository
Hitoshi, Ishikawa

× Hitoshi, Ishikawa

WEKO 1043283

en Hitoshi, Ishikawa

Search repository
Hideyuki, Sakurai

× Hideyuki, Sakurai

WEKO 1043284

en Hideyuki, Sakurai

Search repository
抄録
内容記述タイプ Abstract
内容記述 Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and Methods: Between 2002 and 2017, 110 patients receiving hypofractionated PBT for cT1-2N0M0 NSCLC were reviewed.
Results: Of the 110 patients, 17 were diagnosed with ILD. The median follow-up period was 37.8 months. No significant difference in the 1-year cumulative rate of grade ≥2 pneumonitis was observed between patients with and those without ILD (17.6% vs. 14.1%, p=0.708). The lung doses were significantly lower in patients with than in those without ILD among patients without grade ≥2 neumonitis. There were no significant differences in overall survival or local recurrence-free rates according to the presence of ILD. Conclusion: PBT appears to be a feasible and effective treatment for cT1-2N0M0 NSCLC in
patients with ILD, but the lung dose should be strictly reduced.
書誌情報 Anticancer research

巻 41, 号 11, p. 5635-5642, 発行日 2021-11
出版者
出版者 International Institute of Anticancer Research
ISSN
収録物識別子タイプ ISSN
収録物識別子 0250-7005
PubMed番号
識別子タイプ PMID
関連識別子 34732436
DOI
識別子タイプ DOI
関連識別子 10.21873/anticanres.15379
関連サイト
識別子タイプ URI
関連識別子 https://ar.iiarjournals.org/content/41/11/5635
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 16:53:22.855330
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3